Valuation: Sartorius Stedim Biotech SA

Market Cap 20.67B 23.5B 19.54B 17.72B 33.29B 2,256B 33.48B 234B 90.37B 1,151B 88.22B 86.31B 3,699B P/E 2026 *
54.4x
P/E 2027 * 42x
Enterprise Value 22.68B 25.78B 21.44B 19.45B 36.53B 2,475B 36.74B 257B 99.16B 1,263B 96.8B 94.7B 4,058B EV / Sales 2026 *
7.25x
EV / Sales 2027 * 6.46x
Free-Float
28.47%
Yield 2026 *
0.39%
Yield 2027 * 0.47%
Manager TitleAgeSince
Chief Executive Officer 51 28/03/2023
Chief Tech/Sci/R&D Officer 61 08/09/2011
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 07/04/2015
Director/Board Member 69 07/04/2015
Director/Board Member 69 14/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.29%-2.05%-24.22%+2.80% 175B
+0.55%-3.25%-5.53%+12.81% 113B
-1.02%-4.02%-1.39%+66.13% 58.57B
+0.12%+1.30%-0.52%-30.33% 50.07B
+0.45%+4.36%+15.64%+53.13% 49.92B
-0.13%-3.13%+29.97%-9.51% 32.69B
+0.97%+10.04% - - 30.44B
+1.65%+4.28%+44.92%-0.48% 26.07B
+1.98%+9.34%+26.26%-2.43% 23.55B
Average +0.47%+1.76%+10.64%+11.51% 62.22B
Weighted average by Cap. +0.15%+0.01%-2.70%+12.41%

Financials

2026 *2027 *
Net sales 3.13B 3.56B 2.96B 2.68B 5.04B 341B 5.07B 35.41B 13.68B 174B 13.35B 13.06B 560B 3.47B 3.95B 3.28B 2.98B 5.59B 379B 5.62B 39.3B 15.18B 193B 14.82B 14.5B 621B
Net income 378M 430M 358M 324M 609M 41.28B 613M 4.28B 1.65B 21.06B 1.61B 1.58B 67.69B 482M 548M 456M 413M 776M 52.59B 781M 5.46B 2.11B 26.83B 2.06B 2.01B 86.23B
Net Debt 2.01B 2.29B 1.9B 1.72B 3.24B 219B 3.26B 22.76B 8.79B 112B 8.58B 8.4B 360B 1.76B 2.01B 1.67B 1.51B 2.84B 192B 2.86B 19.97B 7.71B 98.21B 7.53B 7.36B 316B
Logo Sartorius Stedim Biotech SA
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-